Toll-like receptor 2 mediates the activation of human monocytes and endothelial cells by antiphospholipid antibodies.

Published on May 19, 2011in Blood17.543
· DOI :10.1182/BLOOD-2010-11-316158
Nathalie Satta15
Estimated H-index: 15
,
Egbert K. O. Kruithof41
Estimated H-index: 41
+ 5 AuthorsPhilippe de Moerloose44
Estimated H-index: 44
Sources
Abstract
The presence of antiphospholipid antibodies (aPLAs) is associated with arterial or venous thrombosis and/or recurrent fetal loss. The proposed pathogenic mechanisms for aPLA effects include the inflammatory activation of monocytes and endothelial cells. Toll-like receptors (TLRs) are candidate signaling intermediates. The aim of this study was to investigate the relative contribution of TLR2 and TLR4 in cell activation by aPLAs. Of 32 patient-derived aPLAs, 19 induced an inflammatory activation of human monocytes and umbilical vein endothelial cells (HUVECs). In HUVECs, inflammatory responses to these aPLAs were increased by TNF pretreatment, which increases the expression of TLR2 but not TLR4. Anti-TLR2 but not anti-TLR4 antibodies reduced the aPLA-induced activation of monocytes and HUVECs. aPLAs activated TLR2-expressing human embryonic kidney 293 (HEK293) cells but not TLR4-expressing cells. Binding studies demonstrated an interaction between aPLAs and TLR2 but not TLR4. A role for CD14, a coreceptor for TLR2 and TLR4, can be inferred by observations that anti-CD14 antibodies reduced responses to aPLAs in monocytes, and that responses in HEK293 cells expressing TLR2 and CD14 were greater than in HEK293 cells expressing TLR2 alone. Our results demonstrate a role for TLR2 and CD14 in human endothelial cell and monocyte activation by aPLAs.
📖 Papers frequently viewed together
4,748 Citations
175 Citations
187 Citations
References52
Newest
#1C. Ağar (UU: Utrecht University)H-Index: 6
#2Gwendolyn M. A. van Os (UU: Utrecht University)H-Index: 2
Last. Philip G. de Groot (UU: Utrecht University)H-Index: 78
view all 9 authors...
The antiphospholipid syndrome is defined by the presence of antiphospholipid antibodies in blood of patients with thrombosis or fetal loss. There is ample evidence that β2-glycoprotein I (β2GPI) is the major antigen for antiphospholipid antibodies. The autoantibodies recognize β2GPI when bound to anionic surfaces and not in solution. We showed that β2GPI can exist in at least 2 different conformations: a circular plasma conformation and an “activated” open conformation. We also showed that the c...
205 CitationsSource
#1Jean-Eric AlardH-Index: 6
#2Fanny Gaillard (CNRS: Centre national de la recherche scientifique)H-Index: 8
Last. Pierre YouinouH-Index: 68
view all 6 authors...
During the antiphospholipid syndrome, β2-gpI interacts with phospholipids on endothelial cell (EC) surface to allow the binding of autoantibodies. However, induced-pathogenic intracellular signals suggest that β2-gpI associates also with a receptor that is still not clearly identified. TLR2 and TLR4 have long been suspected, yet interactions between TLRs and β2-gpI have never been unequivocally proven. The aim of the study was to identify the TLR directly involved in the binding of β2-gpI on EC ...
71 CitationsSource
#1Anastasia Lambrianides (UCL: University College London)H-Index: 10
#2Christopher CarrollH-Index: 51
Last. Ian Giles (UCL: University College London)H-Index: 28
view all 11 authors...
A major mechanism of hypercoagulability in the antiphospholipid syndrome (APS) is antiphospholipid Ab-mediated upregulation of tissue factor (TF) on monocytes via activation of TLRs, p38 MAPK, and NF-kappaB pathways. We examined whether monocyte signaling pathways are differentially activated by IgG from patients with vascular thrombosis (VT) alone compared with IgG from patients with pregnancy morbidity (PM) alone. We purified IgG from 49 subjects. A human monocyte cell line and ex vivo healthy...
63 CitationsSource
#1H. Zinger (Sheba Medical Center)H-Index: 1
#2Yaniv Sherer (Sheba Medical Center)H-Index: 56
Last. Y. Shoenfeld (Sheba Medical Center)H-Index: 75
view all 12 authors...
Antiphospholipid syndrome is characterized by thrombosis and pregnancy loss. Infections are generally associated with autoimmune diseases, but in the setting of antiphospholipid syndrome this link has been suggested as having a pathogenic role. In this study, 98 patients with antiphospholipid syndrome were screened for antibodies directed to several infectious agents. The main finding in this study is the significantly higher prevalence of IgM antibodies to toxoplasma and rubella. This novel fin...
30 CitationsSource
#1Zurina Romay-Penabad (UTMB: University of Texas Medical Branch)H-Index: 14
#2Maria Guadalupe Montiel-Manzano (UNAM: National Autonomous University of Mexico)H-Index: 1
Last. Silvia S. Pierangeli (UTMB: University of Texas Medical Branch)H-Index: 41
view all 12 authors...
Antiphospholipid (aPL) antibodies recognize receptor-bound β 2 glycoprotein I (β 2 GPI) on target cells, and induce an intracellular signaling and a procoagulant/proinflammatory phenotype that leads to thrombosis. Evidence indicates that annexin A2 (A2), a receptor for tissue plasminogen activator and plasminogen, binds β 2 GPI on target cells. However, whether A2 mediates pathogenic effects of aPL antibodies in vivo is unknown. In this work, we studied the effects of human aPL antibodies in A2-...
117 CitationsSource
#1Omar S. Al-Attas (KSU: King Saud University)H-Index: 36
#2Nasser M. Al-Daghri (KSU: King Saud University)H-Index: 58
Last. Alison L. Harte (Warw.: University of Warwick)H-Index: 30
view all 8 authors...
Introduction Chronic low-grade inflammation is a significant factor in the development of obesity associated diabetes. This is supported by recent studies suggesting endotoxin, derived from gut flora, may be key to the development of inflammation by stimulating the secretion of an adverse cytokine profile from adipose tissue.
106 CitationsSource
#1Oscar-Danilo Ortega-Hernandez (Sheba Medical Center)H-Index: 11
#2Nancy Agmon-Levin (Sheba Medical Center)H-Index: 59
Last. Yehuda Shoenfeld (TAU: Tel Aviv University)H-Index: 143
view all 5 authors...
Abstract Catastrophic antiphospholipid (Asherson's) syndrome (cAPS) was described in the past as a severe variant of the antiphospholipid syndrome (APS). Currently growing evidence suggests it is a unique condition. This statement is based on several clinical and physiopathological features that although not well understood define cAPS by itself. The remarkable features of cAPS are the presence of antiphospholipid antibodies (aPLAs) and microthromboses. Additional physiopathological features are...
55 CitationsSource
#1Nathalie SattaH-Index: 15
Last. Philippe de MoerlooseH-Index: 44
view all 4 authors...
Abstract Human endothelial cells (EC) express Toll-like receptor 4 (TLR4), a receptor for lipopolysaccharides (LPS), but little or no TLR2, a lipopeptide receptor. The aim of this study was to investigate to what extent inflammatory stimuli modify the expression by EC of TLR4 and TLR2, of the TLR2 co-receptors TLR1 and TLR6 and of the TLR2-accessory proteins CD14 and CD36. Stimulation of umbilical vein derived EC with TNF-α, LPS or IL-1β for 24 h induced a strong increase in TLR2 mRNA but not in...
56 CitationsSource
#1Mi Sun Jin (KAIST)H-Index: 9
#2Jie-Oh Lee (KAIST)H-Index: 36
Toll-like receptors (TLRs) play central roles in the innate immune response by recognizing conserved structural patterns in diverse microbial molecules. Here, we discuss ligand binding and activation mechanisms of the TLR family. Hydrophobic ligands of TLR1, TLR2, and TLR4 interact with internal protein pockets. In contrast, dsRNA, a hydrophilic ligand, interacts with the solvent-exposed surface of TLR3. Binding of agonistic ligands, lipopeptides or dsRNA, induces dimerization of the ectodomains...
426 CitationsSource
#1Rolf T. Urbanus (University Medical Center Utrecht)H-Index: 29
#2Maarten T. T. Pennings (UU: Utrecht University)H-Index: 10
Last. P. G. De GrootH-Index: 69
view all 4 authors...
Summary. Background: Dimerization of β2-glycoprotein I (β2-GPI) by autoantibodies is thought to trigger the clinical manifestations observed in the antiphospholipid syndrome. Arterial thrombosis, a frequently occurring clinical manifestation of the antiphospholipid syndrome, is a process in which platelets play a crucial role. Previous work has shown that binding of dimeric β2-GPI to the platelet receptors apolipoprotein E receptor 2′ (ApoER2′) and glycoprotein Ibα (GPIbα) mediates increased pla...
106 CitationsSource
Cited By84
Newest
Source
#2José M. VillalbaH-Index: 40
Last. Carlos Perez-SanchezH-Index: 13
view all 8 authors...
Coenzyme Q10 (CoQ10) is a mitochondrial electron carrier and a powerful lipophilic antioxidant located in membranes and plasma lipoproteins. CoQ10 is endogenously synthesized and obtained from the diet, which has raised interest in its therapeutic potential against pathologies related to mitochondrial dysfunction and enhanced oxidative stress. Novel formulations of solubilized CoQ10 and the stabilization of reduced CoQ10 (ubiquinol) have improved its bioavailability and efficacy. Synthetic analo...
1 CitationsSource
Source
#1Markos D Patsouras (UoA: National and Kapodistrian University of Athens)H-Index: 3
#2E. Tsiki (UoA: National and Kapodistrian University of Athens)H-Index: 1
Last. P. G. Vlachoyiannopoulos (UoA: National and Kapodistrian University of Athens)H-Index: 12
view all 4 authors...
Abstract Objective Antiphospholipid syndrome (APS) is an acquired thrombophilia characterized by recurrent thrombosis and/or pregnancy morbidity, in the presence of antibodies to β2 glycoprotein-I (β2GPI), prothrombin or Lupus anticoagulant (LA). Anti-β2GPI antibodies recognize complexes of β2GPI dimers with CXCL4 chemokine and activate platelets. Thrombospondin 1 (TSP-1) is secreted by platelets and exhibits prothrombotic and proinflammatory properties. Therefore, we investigated its implicatio...
1 CitationsSource
#1Chary López-Pedrera (UCO: University of Córdoba (Spain))H-Index: 26
#2Nuria Barbarroja (UCO: University of Córdoba (Spain))H-Index: 28
Last. Carlos Perez-Sanchez (UCO: University of Córdoba (Spain))H-Index: 13
view all 8 authors...
Rheumatoid Arthritis (RA), Systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) are the systemic autoimmune diseases (SADs) most associated with an increased risk of developing cardiovascular (CV) events. Cardiovascular disease (CVD) in SADs results from a complex interaction between traditional CV-risk factors, immune deregulation and disease activity. Oxidative stress, dyslipidemia, endothelial dysfunction, inflammatory/prothrombotic mediators (cytokines/chemokines, adipokine...
5 CitationsSource
#1Natalia Filippidou (The Cyprus Institute of Neurology and Genetics)H-Index: 1
#2George Krashias (The Cyprus Institute of Neurology and Genetics)H-Index: 3
Last. Anastasia Lambrianides (The Cyprus Institute of Neurology and Genetics)H-Index: 10
view all 5 authors...
Abstract Multiple sclerosis (MS) is a chronic, multifactorial, inflammatory disease of the central nervous system where demyelination leads to neurodegeneration and disability. The pathogenesis of MS is incompletely understood, with prevalence of antiphospholipid antibodies (aPL) speculated to contribute to MS pathogenesis. In fact, MS shares common clinical features with the Antiphospholipid Syndrome (APS) such as venous thromboembolism. Consequently, the presence of aPL which are associated wi...
2 CitationsSource
#1S. V. Shirshev (RAS: Russian Academy of Sciences)H-Index: 5
The review discusses the mechanisms of participation of natural killer T cells (NKT cells) in the induction of antiphospholipid antibodies (APA) that play a major pathogenetic role in the formation of antiphospholipid syndrome (APS), summarizes the data on APS pathogenesis, and presents modern concepts on the antibody formation involving follicular helper type II NK cells.
Source
#1Brigitta Buttari (ISS: Istituto Superiore di Sanità)H-Index: 25
#2Elisabetta Profumo (ISS: Istituto Superiore di Sanità)H-Index: 28
Last. Rachele Riganò (ISS: Istituto Superiore di Sanità)H-Index: 31
view all 6 authors...
AbstractAntiphospholipid antibody syndrome (APS) is a systemic autoimmune disease characterized by arterial and venous thrombosis and/or pregnancy morbidity. The incidence is around five new cases/...
2 CitationsSource
#1Markos D Patsouras (UoA: National and Kapodistrian University of Athens)H-Index: 3
#2Panagiota Karagianni (UoA: National and Kapodistrian University of Athens)H-Index: 5
Last. P. G. Vlachoyiannopoulos (UoA: National and Kapodistrian University of Athens)H-Index: 12
view all 4 authors...
Abstract Background Antiphospholipid syndrome (APS) is an autoimmune thrombophilia characterized by recurrent thromboembolism and/or pregnancy morbidity in the presence of Antiphospholipid antibodies, mainly anti-β2 glycoprotein I (anti-β2GPI). The autoantibodies lead to monocyte and endothelial cell activation and subsequent secretion of tissue factor (F3) and proinflammatory cytokines, like interleukins 6 (IL6) and 8 (IL8). The etiology of the syndrome remains largely unknown, with the contrib...
5 CitationsSource
#1Nathalie Satta (Geneva College)H-Index: 15
#2Miguel Frias (Geneva College)H-Index: 17
Last. Sabrina Pagano (Geneva College)H-Index: 20
view all 4 authors...
BACKGROUND: Autoimmune diseases are closely associated with cardiovascular diseases (CVD). Over the last decades, the comprehension of atherosclerosis, the principal initiator of CVD, evolved from a lipidcentered disease to a predominant inflammatory and immune response-driven disease displaying features of autoimmunity against a broad range of auto-antigens, including lipoproteins. Among them, high density lipoproteins (HDL) are important actors of cholesterol transport and bear several anti-at...
4 CitationsSource